Rutgers University Study of the Genetics of Blood Cancers
Rutgers, The State University of New Jersey · with Regeneron Pharmaceuticals · NCT07714044
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–110 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 10000
- US sites recruiting
- 1
- Study start
- September 22, 2026
- Record last updated
- October 1, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this study is to enroll at least 10,000 participants nationally including affecteds and unaffecteds via online study portal, collect surveys online and a saliva sample through the mail, sequence DNA, and conduct genetic analyses to identify novel variants and further study known variants associated with leukemia, lymphoma, myeloma and other blood cancers.
Conditions: Blood Cancers; Blood Cancer; Leukemia; Lymphoma; Myeloma; Hematologic Cancer; Hematologic Malignancies; Hematologic Neoplasm; Hematologic Tumors
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- age 18 years or older
- currently living in the United States
- have access to the internet and a computer, laptop, tablet or smartphone
- willing to provide written informed consent for participation
- willing to provide DNA via a saliva sample using a collection kit mailed to your home
- willing to complete a survey with questions about health related to the study of blood cancer.
Exclusion Criteria
- Not able to meet or fulfill any of the inclusion criteria
Recruiting US locations
Rutgers University
Piscataway, NJ 08854
Site contact: Tara Matise, PhD · 848-445-3125 · rugcc@rutgers.edu
Study contacts (from the official record)
- Tara Matise, PhD · 848-445-3125 · rugcc-blood-cancer@rutgers.edu
Similar studies in New Jersey
All healthy volunteers studies in New Jersey →- RecruitingHealthy volunteersPhase 1
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
Arcutis Biotherapeutics, Inc.
- Location
- Fair Lawn, NJ + 6 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Clinical Trial of MK-1406 in Healthy Participants (MK-1406-008)
Merck Sharp & Dohme LLC
- Location
- Marlton, NJ + 5 other US sites
- Eligibility basics
- Ages 18–64
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Jersey City, NJ + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
Study of Single Doses of HBS-104 in Acutely Sleep-deprived Healthy Participants
Harmony Biosciences Management, Inc.
- Location
- Eatontown, NJ
- Eligibility basics
- Ages 18–55